​

Spyre Therapeutics (SYRE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Spyre Therapeutics Revenue Highlights

00

Spyre Therapeutics Revenue by Period

Spyre Therapeutics Revenue by Year

DateRevenueChange
2025-12-31-100.00%
2024-12-31--100.00%
2023-12-31$886.00K-61.96%
2022-12-31$2.33M-87.57%
2021-12-31$18.74M100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$3.89M-25.30%
2017-12-31$5.21M12.47%
2016-12-31$4.63M-23.94%
2015-12-31$6.08M100.00%
2014-12-31--

Spyre Therapeutics generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Spyre Therapeutics Revenue by Quarter

DateRevenueChange
2026-03-31--100.00%
2025-12-31$90.49M100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30--100.00%
2023-06-30$688.00K247.47%
2023-03-31$198.00K17.86%
2022-12-31$168.00K-3.45%
2022-09-30$174.00K-72.16%
2022-06-30$625.00K-54.11%
2022-03-31$1.36M-62.62%
2021-12-31$3.64M160.47%
2021-09-30$1.40M-89.79%
2021-06-30$13.70M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--100.00%
2018-06-30$2.38M57.48%
2018-03-31$1.51M1.89%
2017-12-31$1.48M17.53%
2017-09-30$1.26M-

Spyre Therapeutics generated - in revenue during Q1 2026, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Spyre Therapeutics Revenue Breakdown

Spyre Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
License-

Spyre Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARDXArdelyx$407.32M$94.47M
ABCLAbCellera Biologics$75.13M$8.31M
WVEWave Life Sciences$42.73M$38.25M
IMNMImmunome$6.94M-
UPBUpstream Bio$2.85M$1.03M
CLDXCelldex Therapeutics$1.54M$15.00K
NTLAIntellia Therapeutics-$15.05M
PHVSPharvaris--
SYRESpyre Therapeutics--
MAZEMaze Therapeutics--
ZYMEZymeworks$-27.11M-

SYRE Revenue FAQ

What is Spyre Therapeutics’s yearly revenue?

Spyre Therapeutics's yearly revenue for 2025 was $0, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. SYRE's yearly revenue for 2023 was $886K, representing a decrease of -61.96% compared to 2022.

What is Spyre Therapeutics’s quarterly revenue?

Spyre Therapeutics's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $90.49M, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). SYRE's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024).

What is Spyre Therapeutics’s revenue growth rate?

Spyre Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -100.00%, and for the last 5 years (2021-2025) was -100.00%.